Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus

NCT00781547 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT00781547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00781547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus
Lead sponsor
Göteborg University
Phase
Phase 3
Overall status
Completed
Start date
January 31, 1999
Completion date
May 31, 2005
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal obesity, metabolic syndrome, obesity